SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
34,200
+350 (1.03%)
Aug 3, 2026, 3:30 PM KST

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceuticals
651.37B267.55B369.51B456.73B929.00B
Total
651.37B267.55B369.51B456.73B929.00B

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
America
98.37B24.80B185.96B217.83B48.41B
Europe
401.38B107.12B21.20B13.78B184.50B
Asia
10.23B3.55B3.89B651.33M233.27M
South Korea
140.12B131.49B158.22B224.16B695.86B
Middle East
1.27B576.98M231.61M305.04M-
Total
651.37B267.55B369.51B456.73B929.00B